• to decrease the potential risk of major cardiovascular (heart and blood vessel) difficulties in Older people with kind two diabetes and heart problemsNovo Nordisk A/S can be a Danish multinational pharmaceutical company headquartered in Bagsværd,[three] with generation services in 9 international locations and affiliate marketers or workplaces